Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AniCon Labor is a Germany-based animal health and veterinary diagnostics company focused on livestock testing, autogenous vaccines, and feed and food safety services. Founded in 2005 as a service laboratory in Höltinghausen, the company built capabilities across pathology, bacteriology, virology, serology, molecular biology, and related laboratory services for poultry, swine, cattle, sheep, goats, and fish. In June 2021, SAN Group acquired AniCon Labor GmbH, and the business now operates within SAN Vet under the legal name SAN Group Biotech Germany GmbH while continuing to use the AniCon brand in parts of its offering. The company appears to be commercial-stage rather than a drug-development biotech, with revenue generated from diagnostic services, livestock-specific autogenous vaccines, and food/feed safety testing. Its business is healthcare-related through veterinary diagnostics and immunization rather than human therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AniCon Labor.